XILIO THERAPEUTICS INC (XLO) Stock Balance Sheet
NASDAQ:XLO - Nasdaq - US98422T1007 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 61.26M | 44.70M | 120.40M | 198.10M | 19.20M | |||
| Other Current Assets | 2.05M | 3.42M | 4.10M | 4.50M | 1.30M | |||
| Total Current Assets | 63.31M | 48.13M | 124.50M | 202.50M | 20.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.57M | 11.20M | 13.10M | 13.90M | 13.70M | |||
| Other Non-Current Assets | 1.77M | 1.60M | 1.60M | 1.60M | 2.10M | |||
| Total Non-Current Assets | 11.35M | 12.80M | 14.70M | 15.60M | 15.70M | |||
| TOTAL ASSETS | 74.66M | 60.93M | 139.20M | 218.10M | 36.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 3.36M | 6.70M | 100.00K | 2.40M | |||
| Accrued Expenses | 10.95M | 11.54M | 11.20M | 9.60M | 14.30M | |||
| Accounts Payable | 972.00K | 1.05M | 3.10M | 3.10M | 5.40M | |||
| Other Current Liabilities | 26.11M | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 38.02M | 15.96M | 21.10M | 12.80M | 22.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 3.20M | 9.70M | 7.60M | |||
| Other Non-Current Liabilities | 15.66M | 8.14M | 9.20M | 10.10M | 11.80M | |||
| Total Non-Current Liabilities | 15.66M | 8.14M | 12.40M | 19.80M | 19.40M | |||
| TOTAL LIABILITIES | 53.68M | 24.10M | 33.50M | 32.60M | 41.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -370.66M | -325.51M | -249.10M | -160.90M | -85.10M | |||
| Additional Paid In Capital | 391.63M | 362.34M | 354.80M | 346.30M | 1.80M | |||
| Common Shares | 4.00K | 3.00K | 0.00 | 0.00 | 78.00M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 0.00 | N/A | |||
| Shares Outstanding | 43.96M | 27.61M | 27.40M | 27.40M | 26.70M | |||
| Tangible Book Value per Share | 0.48 | 1.33 | 3.85 | 6.77 | -3.12 | |||
| Total Shareholders' Equity | 20.97M | 36.83M | 105.60M | 185.40M | -5.30M | |||
| TOTAL LIABILITIES AND EQUITY | 74.66M | 60.93M | 139.20M | 218.10M | 36.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.03 | 0.05 | -1.43 | |||
| Current Ratio | 1.67 | 3.02 | 5.90 | 15.82 | 0.93 | |||
| Return On Assets (ROA) | -84.12% | -125.40% | -63.38% | -34.75% | -152.12% | |||
| Return On Equity (ROE) | -299.43% | -207.47% | -83.54% | -40.88% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21